arrow
F

Fernanda Tavares Da Silva

GlaxoSmithKline
H指数:23
被引数:2,885

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study

带有AS03佐剂的变体适应SARS-CoV-2重组蛋白疫苗作为授权疫苗的成人助推器的安全性和免疫原性: 一项3期平行组研究

2023-08-018
OAAI
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2 randomised, dose-finding, multicentre study
2022-05-0143
OAAI
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2 dose-ranging study ,
2021-09-0186
OAAI
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study
2020-06-0110
OAAI
Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

佐剂重组带状疱疹疫苗的研制及其对带状疱疹的预防意义

2018-07-2088
OAAI